Do we continue hormonal treatment after hormone resistance?
Jones, W.G.
Progress in Clinical and Biological Research 303: 331-336
1989
ISSN/ISBN: 0361-7742 PMID: 2674994 Document Number: 342305
Document emailed within 1 workday
Related Documents
Blumer, D.; Migeon, C. 1975: Hormone and hormonal agents in the treatment of aggression Journal of Nervous and Mental Disease 160(2-1): 127-137Drapier-Faure, E. 2003: There are reasons to continue hormone replacement therapy longer than 10 years Gynecologie Obstetrique and Fertilite 31(2): 189-90; Author Reply 193-4
Lauritzen, C. 1979: Hormonal regulation and hormone therapy in childhood and adolescence. Part 1: development of endocrine glands, hormone production, menarche and secondary sex characteristics Fortschritte der Medizin 97(18): 863-868
Horodnicki, J.M.; Pobocha, J.; Czekalski, S.; Wdowiak, J.; Szakowski, A. 1988: Relations between therapeutic and hormonal response to neuroleptics of patients with paranoid schizophrenia. III. Secretion of growth hormone (GH), adrenocorticotropic hormone (ACTH), cortisol (CORT) and insulin (INS) Psychiatria Polska 22(4): 290-295
Collet, P. 2002: Hormone replacement therapy for menopause: continue or stop the prescription after 10 years? Should hormone replacement therapy be continued after 10 years? of course not! Gynecologie Obstetrique and Fertilite 30(9): 736-739
Samandari, G.; O'Connell, K.A. 2011: "If we can endure, we continue": understanding differences between users, discontinuers, and non-users of hormonal contraceptive methods in Pursat Province, Cambodia Women and Health 51(3): 256-278
Kazakov, V.K.; Rosochacki, S.J.; Ignat'eva, T.V.; Golinskiĭ, G.F.; Smirnov, A.F. 1994: An immunocytochemical analysis of the hormonal status of animals transgenic for growth hormone genes and for a mini-gene of human growth hormone-releasing factor Tsitologiia 36(4): 372-377
Bas-Lando, M.; Rabinowitz, R.; Farkash, R.; Algur, N.; Rubinstein, E.; Schonberger, O.; Eldar-Geva, T. 2017: Prediction value of anti-Mullerian hormone (AMH) serum levels and antral follicle count (AFC) in hormonal contraceptive (HC) users and non-HC users undergoing IVF-PGD treatment Gynecological Endocrinology: the Official Journal of the International Society of Gynecological Endocrinology 33(10): 797-800
Kraljić, I.; Tarle, M. 1987: Evaluation of endocrine therapy of prostate cancer by assessing tumor markers and hormone parameters. Hormonal "cross-over" treatment of false endocrine independent tumors Progress in Clinical and Biological Research 243b: 521-525
Tar, A.; Postel-Vinay, M.C.; Brauner, R.; Rappaport, R. 1992: Determination of growth hormone binding protein in a normal population and in subjects with short stature due to growth hormone resistance Orvosi Hetilap 133(12): 721
Sunthornthepvarakul, T.; Jaruratanasirikul, S.; Likitmaskul, S.; Angsusingha, K.; Ngowngarmratana, S. 2000: An identical neo-mutation in the thyroid hormone receptor beta gene (A317T) in 2 unrelated Thai families with resistance to thyroid hormone Journal of the Medical Association of Thailand 83(2): 139-145
Poyrazoğlu, S.ük.; Tütüncüler, F.; Baş, F.; Darendeliler, F. 2008: Resistance to thyroid hormone in a Turkish child with A317T mutation in the thyroid hormone receptor-beta gene Turkish Journal of Pediatrics 50(6): 577-580
Orias, R. 1968: Effect of hypothalamic extracts and stress on the pituitary melanocyte stimulating hormone content in rats abstract in vitro rana pipiens skin follicle stimulating hormone luteinizing hormone growth hormone oxytocin hormone vasopressin hormone Proceedings Int Union Physiology Science 7(24): 332
Orias, R. 1968: Effect of hypothalamic extracts and stress on the pituitary melanocyte stimulating hormone content in rats abstract in vitro rana pipiens skin follicle stimulating hormone luteinizing hormone growth hormone oxytocin hormone vasopressin hormone Proceedings Int Union Physiology Science 7(24): 332
Jamin, C. 2003: Traitement hormonal de la ménopause et risque vasculaire : Le traitement hormonal substitutif : WHI un an après - Hormonal treatment of menopause and vascular risk la Lettre du Gynecologue (283): 27-30
1994: Advances in hormonal contraception. A new micro-pll with especially low hormone effect Der Gynakologe 27(2 Suppl): 1-12
Csaba, G.; Németh, G. 1980: Enhancement of the sensitivity of Tetrahymena to a second hormonal influence by hormone pretreatment Acta Biologica et Medica Germanica 39(10): 1027-1030
Nenci, I. 1979: Cytochemistry of the hormonal receptors in hormone-responsive tumors. the role of the pathologist Pathologica 71(1014): 431-441
Predná, L.; Habánová, M.; Sláviková, E.; Wyka, J. 2015: Hormonal contraceptives and hormone replacement therapy as a possible factor of breast cancer Roczniki Panstwowego Zakladu Higieny 66(3): 269-274
Ohisalo, J. 1991: Hormone resistance Duodecim; Laaketieteellinen Aikakauskirja 107(1): 68-70